![]()
FEB/MAR 2006 Research Activities at a Featured Program |
SRNT NewsletterAdvancing Science & Health February/March 2006, Volume 12, Number 1
Highlights from SRNT's 12th Annual Meeting
|
||||||||||
|
On February 15, two pre-conference workshops were held. The first was entitled National Cooperative Drug Discovery Groups for Nicotine Addiction - A NIDA Synthesis Meeting. This NIDA-sponsored meeting featured a full day of in-depth presentations highlighting the range of ligand discovery and development research from basic science to clinical trials currently funded under the National Cooperative Drug Discovery Groups (NCDDG). The second meeting was an afternoon session entitled Addressing Tobacco in Health Care National Forum - Translating Health Services Research into Practice and Policy. This meeting was coordinated by the Addressing Tobacco in Managed Care National Program Office and funded by The Robert Wood Johnson Foundation. Attendees were provided with the opportunity to discuss two emerging opportunities in systems changes and tobacco control: the upcoming PHS Guideline update and applying lessons from tobacco to other health risk behaviors.
Later that evening, an opening reception was well-attended, arranged by our Local Host Committee, chaired by David Drobes, Ph.D., who also served as SRNT Program Chair in 2005. The formal scientific program began on February 16, covering pre-clinical, clinical, and public health/epidemiological research topics on nicotine and tobacco. Featured lecturers, symposia, and oral paper sessions were balanced across these themes, with a number of sessions emphasizing integration across levels of analysis.
|
(L-R) Keynote Speaker Robert West and SRNT Past President David Balfour |
The Program Committee reviewed twenty-one symposia submissions, and those considered the timeliest, of the highest quality, and most integrative across the diverse interests among SRNT members were included in the scientific program. The titles of those symposia presented at the meeting were as follows:
Applying similar criteria, twelve oral paper sessions were organized around the following themes:
|
(L-R) Ken Perkins, 2006 Langley Award recipient Bill
Corrigall, and Neal Benowitz, (SRNT Awards Committee Chair) |
The accomplishments of several SRNT members were recognized at the meeting. The 2006 Langley Award for Basic Research on Nicotine and Tobacco was presented to Dr. William Corrigall, who provided a career retrospective and directions for future research in his address entitled Nicotine Addiction: Discovery Research Then and Now during the Awards Presentation session on Saturday, February 18. Judith Wilkenfeld, J.D., (Campaign for Tobacco Free Kids) was awarded the John Slade Prize, which recognizes outstanding contributions to public health and tobacco control through science-based public policy and policy advocacy.
|
(L-R) Mitch Zeller, John Slade Award recipient
Judith Wilkenfeld, and Neal Benowitz |
|
(L-R) Rachel Tyndale, 2006 Young Investigator Award
recipient Bernard Le Foll, and Neal Benowitz |
The SRNT Member's Meeting included a Presidential report by Dr. David Balfour, who provided a review of the proposed by-law changes and answered several questions raised by members in attendance. A review of the SRNT budget and fiscal policy was provided by Secretary/Treasurer Dr. Laura Cousino-Klein. The Chair of the SRNT Nominations Committee, Dr. Neil Grunberg, announced that the incoming President-Elect is Dr. Raymond Niaura (Brown Medical School and Butler Hospital) and the incoming European Member Delegate is Dr. Jacques Le Houezec (Amzer Glas, France). In addition, Dr. Abu Abdullah has stepped down as Africa, Asia, Oceanna, Latin America (AAOLA) member delegate because he is now living in the U.S.; Dr. Mira Aghi (India) will replace him on the Board.
During the last session of the meeting, the SRNT Presidency was transferred from Dr. David Balfour to Dr. Ellen Gritz. Dr. Gritz and Dr. Eric Donny (2007 SRNT Program Chair) both promoted our next annual meeting, to be held in Austin, Texas.
In summary, the 2006 SRNT meeting was extremely successful in bringing together nicotine and tobacco researchers from diverse disciplines, scientific perspectives, and geographic regions. Colleagues from academia, government, and industry interacted with one another and heard about the latest and most important research findings in the nicotine and tobacco field. Sessions were well-attended, and participants collectively expressed enthusiasm for the plenary lecturers and other sessions. The Coronado Springs Resort proved a very good setting for the meeting; its conference facilities were complemented by outstanding sunny weather throughout.
Audio recordings of all of the meeting sessions (CD and MP3 formats) are available for purchase at www.mobiltape.com. The entire conference in MP3 format is only $99.99.
The 13th Annual Meeting of SRNT will be held in Austin, Texas, February 21-24, 2007, at the Hilton Austin. In addition, the 9th Annual SRNT European meeting will be held September 23-26, 2006 at the Pine Bay Resort in Kusadasi/Ephesus, Turkey. Plan to attend! As always, be sure to check out www.srnt.org for up-to-date conference information.
About the Authors
Suzanne Colby, Ph.D., is Associate Professor of Psychiatry and Human Behavior at the Center for Alcohol
and Addiction Studies, Brown University. She conducts laboratory-based research on tobacco withdrawal
and the reinforcement value of smoking in adolescents, as well as clinical treatment outcome trials
for adolescent tobacco dependence.
Eric Donny, Ph.D., is Assistant Professor in the Department of Psychology at the University of Pittsburgh. He conducts animal and human laboratory research on the factors that influence the emergence of nicotine self-administration and dependence.
Jennifer Tidey, Ph.D., is Assistant Professor of Psychiatry and Human Behavior at the Center for Alcohol and Addictions Studies, Brown University. She conducts laboratory research on biological and environmental factors that affect smoking in people with serious mental illness, and treatment trials that incorporate contingency management and pharmacologic components.